It's crunch time for biotech projects started on a bet that the industry would shake off its multiyear malaise.

The research got the thrust after the Department of Biotechnology (DBT), Ministry of Science and Technology and Indian Space ...

Of the 102 company launches or series A financings since October 2023, just nine had a woman at the helm, according to a ...

At the J.P. Morgan Healthcare Conference, the Biotech CEO Sisterhood assembled in Union Square to showcase the large group of ...

Union Minister Dr. Jitendra Singh called on the States to establish “BioE3 Cells” as part of India’s biotechnology revolution ...

Dr. Singh urged states to establish ‘BioE3 Cells’ in collaboration with the Centre through the Department of Biotechnology (DBT).

Two sizable companies and a handful of small Asian issuers were listed in the US this past week. Read more here.

Variant Bio recently announced a multimillion-dollar deal with a pharmaceutical company, and some of that money will go to ...

Alex Etsell, senior portfolio manager and partner at Toronto-based Hillsdale Investment Management, believes investing in ...

The company's market capitalization of approximately $1.1 billion as of August 2024 positions it as a mid-cap player in the biotechnology space. The company's XmAb technology platform is a key ...

AI-powered simulation software could help biomanufacturers understand the economics and sustainability of protein production at large scale.